Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis

Overview of attention for article published in Patient preference and adherence, June 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 22,866 followers.

RT @mapex_sefh: Long-term natalizumab treatment is associated with sustained improvements in quality of life in EM #Mapex_EM https://t.co/…

RT @OhioHealthMS: Long-term natalizumab treatment is associated with sustained improvements in quality of life in pwMS https://t.co/VvHvZL…

RT @mapex_sefh: Long-term natalizumab treatment is associated with sustained improvements in quality of life in EM #Mapex_EM https://t.co/…

RT @mapex_sefh: Long-term natalizumab treatment is associated with sustained improvements in quality of life in EM #Mapex_EM https://t.co/…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.